Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Xu, Jianpinga | He, Jiayingb | Yang, Huiyib | Luo, Xiaodib | Liang, Zhangminb | Chen, Jiaxinb | Cai, Zhipingb | Xu, Jiasenb | Ren-Heidenreich, Lifenb; *
Affiliations: [a] Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, China | [b] SurExam Bio-Tech Co., Guangzhou, Guangdong, China
Correspondence: [*] Corresponding author: Lifen Ren-Heidenreich, PhD, Global Chief Scientific Officer, SurExam Bio-Tech Co., Guangzhou Technology Innovation Base, 80 Lanyue Road, Science City, Guangzhou 510663, China. http://www.surexam.com/, My US Mobile: 401 206 2931; Fax: +86 20 3205 7122; E-mail: [email protected]/[email protected].
Abstract: The prevalence of EGFR, KRAS, BRAF and PIK3CA somatic mutations in 861 randomly selected Chinese patients with non-small cell lung cancer (NSCLC) was assayed by the SurPlex®-xTAG70plex platform and analyzed. The results showed that the occurrence rates were 41.0, 8.0, 0.7 and 3.7%, respectively. The mutation rates significantly correlated with gender, histology and smoking history. The EGFR exon 19, 20 and 21 mutations were higher in females compared to males (p< 0.001, exon 19 and 21; p=0.018, exon 20), higher in adenocarcinomas compared to other forms of lung cancers (p< 0.001, exon 19 and 21; p=0.035, exon 20), and higher in non-smokers compared to smokers (p< 0.001, exon 19 and 21; p=0.029, exon 20). Conversely, the KRAS mutations were higher in males compared to females (p=0.004), higher in adenocarcinomas compared to other forms of lung cancers (p< 0.001), and higher in smokers compared to non-smokers (p< 0.001). The PIK3CA mutation rate was lower in adenocarcinomas compared to other forms of lung cancers (p=0.003).
Keywords: EGFR signaling pathway, somatic mutations, non-small cell lung cancers, biomarker, Chinese patients, liquidchip
DOI: 10.3233/CBM-2012-0233
Journal: Cancer Biomarkers, vol. 10, no. 2, pp. 63-69, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]